Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series
Overview
Overview
Journal
J Clin Immunol
Publisher
Springer
Specialty
Allergy & Immunology
Date
2023 Apr 24
PMID
37093405
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Miskovic R, Ljubicic J, Bonaci-Nikolic B, Petkovic A, Markovic V, Rankovic I Front Immunol. 2024; 15:1324679.
PMID: 38500873 PMC: 10945545. DOI: 10.3389/fimmu.2024.1324679.
References
1.
Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Foca E
. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020; 31(5):565-569.
PMC: 7264678.
DOI: 10.1111/pai.13263.
View
2.
Devassikutty F, Jain A, Edavazhippurath A, Joseph M, Peedikayil M, Scaria V
. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature. Pediatr Allergy Immunol Pulmonol. 2021; 34(3):115-118.
PMC: 8664121.
DOI: 10.1089/ped.2021.0002.
View
3.
Squire J, Joshi A
. Response to mRNA COVID-19 vaccination in three XLA patients. Vaccine. 2022; 40(36):5299-5301.
PMC: 9345887.
DOI: 10.1016/j.vaccine.2022.07.046.
View
4.
Lindahl H, Klingstrom J, Da Silva Rodrigues R, Christ W, Chen P, Ljunggren H
. Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant. J Clin Immunol. 2022; 42(6):1130-1136.
PMC: 9090539.
DOI: 10.1007/s10875-022-01283-9.
View
5.
Yamasoba D, Kosugi Y, Kimura I, Fujita S, Uriu K, Ito J
. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. Lancet Infect Dis. 2022; 22(7):942-943.
PMC: 9179126.
DOI: 10.1016/S1473-3099(22)00365-6.
View